Titan Spine Celebrates 18k Implantations of Interbody Fusion Device

Spinal Tech

Mequon, Wis.-based Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device. The company is approaching an annualized sales revenue run-rate of $20 million.

Titan Spine has been growing steadily over the past 12 months, and recently signed a distribution agreement with Biomet.

More Articles on Devices:

Mitek Sports Medicine Launches RIGIDFIX ACL Reconstruction System
Alphatec Spine Loses $14.5M in Q3 After PurGen Device Discontinuation
DMP Spine Biologics to Distribute Bacterin Bone Graft Products in Europe

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers